Naruto Taira

  • 918 Citations
  • 19 h-Index
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Naruto Taira is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 36 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Breast Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Estrogen Receptors Medicine & Life Sciences
Quality of Life Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2001 2019

  • 918 Citations
  • 19 h-Index
  • 78 Article
  • 1 Comment/debate

A remarkable uptake of FDG in huge mediastinal hashimoto’s goiter

Oka, K., Hosoya, T., Taira, N. & Otsuka, F., Jan 15 2019, In : Internal Medicine. 58, 2, p. 313-314 2 p.

Research output: Contribution to journalComment/debate

Hashimoto Disease

Evaluation of Therapeutic Target Gene Expression Based on Residual Cancer Burden Classification After Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer

Takahashi, Y., Iwamoto, T., Suzuki, Y., Kajiwara, Y., Hatono, M., Tsukioki, T., Kawada, K., Kochi, M., Ikeda, H., Shien, T., Taira, N., Matsuoka, J., Doihara, H. & Toyooka, S., Jan 1 2019, (Accepted/In press) In : Clinical Breast Cancer.

Research output: Contribution to journalArticle

Residual Neoplasm
Breast Neoplasms
Gene Expression
Drug Therapy
Estrogen Receptors

Influence of breast density on breast cancer risk: a case control study in Japanese women

Nishiyama, K., Taira, N., Mizoo, T., Kochi, M., Ikeda, H., Iwamoto, T., Shien, T., Doihara, H., Ishihara, S., Kawai, H., Kawasaki, K., Ishibe, Y., Ogasawara, Y. & Toyooka, S., Jan 1 2019, (Accepted/In press) In : Breast Cancer.

Research output: Contribution to journalArticle

Case-Control Studies
Breast Neoplasms
Body Mass Index
Odds Ratio

A randomized, open-label, Phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: the Japan Breast Cancer Research Group-M05 PRECIOUS study

Yamamoto, Y., Iwata, H., Ueno, T., Taira, N., Kashiwaba, M., Takahashi, M., Tada, H., Tsugawa, K., Toyama, T., Niikura, N., Hara, F., Fujisawa, T., Yoshinami, T., Saji, S., Takano, T., Masuda, N., Morita, S., Toi, M. & Ohno, S., Sep 1 2018, In : Japanese Journal of Clinical Oncology. 48, 9, p. 855-859 5 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Disease-Free Survival
Drug Therapy
Total Lung Capacity
Lung Transplantation
Single Nucleotide Polymorphism